The alarming rate of obesity and weight gain in industrialized nations is one of the most concerning health issues plaguing developed countries today. Scientists might have just come much closer to finally ending this epidemic by preventing mice from gaining weight even with a steady diet of high-fat food. Could these findings lead to effortless weight loss?
Published on eLife, the study described how scientists from Washington University School of Medicine basically activated certain pathways in fat cells, which essentially allowed the mice to go on a high-fat diet without becoming obese. This could lead to some huge leaps in treating all the other diseases that are associated with weight gain, including type-2 diabetes.
“Here by inducing expression of constitutively active Smoothened (SmoM2) or Gli2 (ΔNGli2) in the adipocyte lineage of postnatal mice, we show that targeted activation of Hh signaling suppresses high-fat-diet-induced obesity and improves whole-body glucose tolerance and insulin sensitivity,” the study reads.
As senior investigator Fanxin Long, Ph.D. put it, these findings could lead to new ways to treat the growing obesity epidemic afflicting populations even in developing countries. It also makes preventing weight gain easier because it targets the root cause of the issue.
"This could lead us to a new therapeutic target for treating obesity," Long said. "What's particularly important is that the animals in our study ate a high-fat diet but didn't gain weight, and in people, too much fat in the diet is a common cause of obesity."
On that note, translating the results of this study to apply to humans might not be that easy, MedicalXpress reports. The test subjects and people don’t exactly have the same metabolism and the methods used to activate the pathways in fat cells to stop them from growing might cause unknown side-effects. It might even cause cancer if the application is not done properly.


CDC Monitors U.S. Travelers After Hantavirus Outbreak on Luxury Cruise Ship
Supreme Court Asked to Reinstate Mail-Order Access to Abortion Pill Mifepristone
Lost in space: MethaneSat failed just as NZ was to take over mission control – here’s what we need to know now
Novartis’ Vanrafia Shows Strong Phase 3 Results in IgA Nephropathy, Paving Way for Full Approval
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
NASA's Artemis II Crew Arrives in Florida for Historic Moon Mission
U.S. Officials Express Optimism Over New CDC Director Selection Amid Vaccine Policy Turmoil
Astronomers have discovered another puzzling interstellar object − this third one is big, bright and fast
Moderna Stock Drops After FDA Declines Review of mRNA Flu Vaccine
Trump Reportedly Approves Plan to Remove FDA Commissioner Marty Makary Amid Growing Controversies
The four types of dementia most people don’t know exist
Is space worth the cost? Accounting experts say its value can’t be found in spreadsheets
SpaceX’s Starship Completes 11th Test Flight, Paving Way for Moon and Mars Missions
Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment 



